Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19

Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19

Antiphospholipid antibodies (aPLA) are a laboratory criterion for the classification of antiphospholipid syndrome (APS) and are known to cause clinical symptoms such as vascular thrombosis or obstetric complications. It is suggested that aPLA may be associated with thromboembolism in severe COVID-19...

Full description

Bibliographic Details
Main Authors: Mirjana Zlatković-Švenda, Milica Ovuka, Manca Ogrič, Saša Čučnik, Polona Žigon, Aleksandar Radivčev, Marija Zdravković, Goran Radunović
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
COVID-19
antiphospholipid syndrome
vascular thrombosis
antiphospholipid antibodies
anticardiolipin antibodies (aCL)
anti-β2-glycoprotein I antibodies (anti-β2GPI)
Online Access:https://www.mdpi.com/2227-9059/11/12/3117

Internet

https://www.mdpi.com/2227-9059/11/12/3117

Similar Items